Biopharmaceutical company BioNTech has announced a major investment of up to £1 ($1.3) billion over 10 years in the UK, potentially creating more than 400 new jobs in London and Cambridge. The latest expansion of BioNTech’s presence in the UK builds on the company’s longstanding, positive strategic relationship and experience of later-stage cancer research and […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!